[1] KAWAGOE K, TAKEDA J, ENDO Y, et al. Molecular cloning of murine pig-a, a gene for GPI-anchor biosynthesis, and demonstration of interspecies conservation of its structure, function, and genetic locus[J]. Genomics, 1994, 23(3):566-574.
[2] KRÜGER C T, FISCHER B M, ARMANT O, et al. The in vitro PIG-A gene mutation assay:glycosylphosphatidylinositol (GPI)-related genotypeto-phenotype relationship in TK6 cells[J]. Arch Toxicol, 2016, 90(7):1729-1736.
[3] HANCOCK J F. GPI-anchor synthesis:ras takes charge[J]. Dev Cell, 2004, 6(6):743-745.
[4] ZELLER A, PFUHLER S, ALBERTINI S, et al. A critical appraisal of the sensitivity of in vivo genotoxicity assays in detecting human carcinogens[J]. Mutagenesis, 2018, 33(2):179-193.
[5] PREIS M, LOWREY C H. Laboratory tests for paroxysmal nocturnal hemoglobinuria[J]. Am J Hematol, 2014, 89(3):339-341.
[6] OLSEN A K, DERTINGER S D, KRÜGER C T, et al. The pig-a gene mutation assay in mice and human cells:a review[J]. Basic Clin Pharmacol Toxicol, 2017, 121(Sup 3):78-92.
[7] DOBROVOLSKY V N, ELESPURU R K, BIGGER C A, et al. Monitoring humans for somatic mutation in the endogenous PIG-A gene using red blood cells[J]. Environ Mol Mutagen, 2011, 52(9):784-794.
[8] LAWRENCE R, HABOUBI H, WILLIAMS L, et al. Dietary and lifestyle factors effect erythrocyte PIG-A mutant frequency in humans[J]. Mutagenesis, 2020, 35(5):405-413.
[9] TOROUS D K, AVLASEVICH S L, KHATTAB M G, et al. Human blood PIG-A mutation and micronucleated reticulocyte flow cytometric assays:Method optimization and evaluation of intra- and inter-subject variation[J]. Environ Mol Mutagen, 2020, 61(8):807-819.
[10] SHEMANSKY J M, MCDANIEL L P, KLIMAS C, et al. Pig-a gene mutation database[J]. Environ Mol Mutagen, 2019, 60(8):759-762.
[11] Frtschl R, Müller L. ICH guideline M7(R1) on assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk[EB/OL]. (2021-04-13). https://www.ema.europa.eu/en/documents/scientific-guideline/ich-guideline-m7r1-assessment-control-dna-reactive-mutagenic-impurities-pharmaceuticals-limit_en.pdf.
[12] MIURA D, DOBROVOLSKY V N, KASAHARA Y, et al. Development of an in vivo gene mutation assay using the endogenous Pig-A gene:I. Flow cytometric detection of CD59-negative peripheral red blood cells and CD48-negative spleen T-cells from the rat[J]. Environ Mol Mutagen, 2008, 49(8):614-621.
[13] DERTINGER S D, AVLASEVICH S L, BEMIS J C, et al. Human erythrocyte PIG-A assay:an easily monitored index of gene mutation requiring low volume blood samples[J]. Environ Mol Mutagen, 2015, 56(4):366-377.
[14] RONDELLI T, BERARDI M, PERUZZI B, et al. The frequency of granulocytes with spontaneous somatic mutations:a wide distribution in a normal human population[J]. PLoS One, 2013, 8(1):e54046.
[15] MIURA D, DOBROVOLSKY V N, MITTELSTAEDT R A, et al. Development of an in vivo gene mutation assay using the endogenous Pig-A gene:II. Selection of Pig-A mutant rat spleen T-cells with proaerolysin and sequencing Pig-A cDNA from the mutants[J]. Environ Mol Mutagen, 2008, 49(8):622-630.
[16] NOJI H, SHICHISHIMA T, SAITOH Y, et al. The distribution of PIGA gene abnormalities in paroxysmal nocturnal hemoglobinuria granulocytes and cultured erythroblasts[J]. Exp Hematol, 2001, 29(4):391-400.
[17] HORIBATA K, UKAI A, ISHIKAWA S, et al. Monitoring genotoxicity in patients receiving chemotherapy for cancer:application of the PIG-A assay[J]. Mutat Res Genet Toxicol Environ Mutagen, 2016, 808:20-26.
[18] CAO Y, YANG L, FENG N, et al. A population study using the human erythrocyte PIG-A assay[J]. Environ Mol Mutagen, 2016, 57(8):605-614.
[19] CASTEL P, CARCOPINO X, ROBERT S, et al. The PIG-A gene as a new biomarker of mutagenesis:proof of concept and technical specifications[J]. Med Sci:Paris, 2017, 33(4):432-439.
[20] DERTINGER S D, AVLASEVICH S L, BEMIS J C, et al. Human erythrocyte PIG-A assay:an easily monitored index of gene mutation requiring low volume blood samples[J]. Environ Mol Mutagen, 2015, 56(4):366-377.
[21] RONDELLI T, BERARDI M, PERUZZI B, et al. The frequency of granulocytes with spontaneous somatic mutations:a wide distribution in a normal human population[J]. PLoS One, 2013, 8(1):e54046.
[22] KOPP B, VIGNARD J, MIREY G, et al. Genotoxicity and mutagenicity assessment of food contaminant mixtures present in the French diet[J]. Environ Mol Mutagen, 2018, 59(8):742-754.
[23] TIAN X, CHEN Y, NAKAMURA J. Development of a novel gene mutation assay based on a GPI-anchored fluorescent protein sensor[J]. Genes Environ, 2019, 41(1):1-10.
[24] DOBROVOLSKY V N, HEFLICH R H. The human RBC PIG-A gene mutation assay[M]//Genotoxicity and DNA Repair. New York:Springer, 2014:169-183.
[25] 范臻佳, 金丽兰, 史册, 等. 急性髓系白血病患者外周血粒细胞、单核细胞膜GPI锚链和红细胞表面CD59表达水平的研究[J]. 现代检验医学杂志, 2019, 34(1):26-28, 33.
[26] BRODSKY R A. Advances in the diagnosis and therapy of paroxysmal nocturnal hemoglobinuria[J]. Blood Rev, 2008, 22(2):65-74.
[27] 李若婉, 周长慧, 黄鹏程, 等. 人类磷脂酰肌醇聚糖A类基因突变在遗传毒性研究中应用进展[J]. 中国药理学与毒理学杂志, 2019, 33(2):147-151.
[28] CAO Y Y, WANG X L, LIU W Y, et al. The potential application of human PIG-A assay on azathioprine-treated inflammatory bowel disease patients[J]. Environ Mol Mutagen, 2020, 61(4):456-464.
[29] DOBROVOLSKY V N, ELESPURU R K, BIGGER C A H, et al. Monitoring humans for somatic mutation in the endogenous pig-a gene using red blood cells[J]. Environ Mol Mutagen, 2011, 52(9):784-794.
[30] HU R, MUKHINA G L, PIANTADOSI S, et al. PIG-A mutations in normal hematopoiesis[J]. Blood, 2005, 105(10):3848-3854.
[31] WARE R E, PICKENS C V, DECASTRO C M, et al. Circulating PIG-A mutant T lymphocytes in healthy adults and patients with bone marrow failure syndromes[J]. Exp Hematol, 2001, 29(12):1403-1409.
[32] ARATEN D J, GOLDE D W, ZHANG R H, et al. A quantitative measurement of the human somatic mutation rate[J]. Cancer Res, 2005, 65(18):8111-8117.
[33] ARATEN D J, NAFA K, PAKDEESUWAN K, et al. Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals[J]. Proc Natl Acad Sci USA, 1999, 96(9):5209-5214.
[34] DERTINGER S D, AVLASEVICH S, BEMIS J, et al. Flow cytometric assessment of PIG-A mutation and micronucleus frequencies in healthy human volunteers and chemotherapy patients[J]. Environ Mol Mutagen, 2016, 57(sup1):60.
[35] CAO Y Y, YANG L, FENG N N, et al. A population study using the human erythrocyte PIG-A assay[J]. Environ Mol Mutagen, 2016, 57(8):605-614.
[36] MCDIARMID M A, ALBERTINI R J, TUCKER J D, et al. Measures of genotoxicity in Gulf war I veterans exposed to depleted uranium[J]. Environ Mol Mutagen, 2011, 52(7):569-581.
[37] CAO Y Y, WANG T W, XI J, et al. PIG-A gene mutation as a genotoxicity biomarker in human population studies:an investigation in lead-exposed workers[J]. Environ Mol Mutagen, 2020, 61(6):611-621.
[38] TRAULSEN A, PACHECO J M, DINGLI D. On the origin of multiple mutant clones in paroxysmal nocturnal hemoglobinuria[J]. Stem Cells, 2007, 25(12):3081-3084.
[39] PACHECO-MARTÍNEZ M M, CORTÉS-BARBERENA E, CERVANTESRÍOS E, et al. Moderate malnutrition in rats induces somatic gene mutations[J]. Mutat Res-Fund Mol M, 2016, 789:26-32.
[40] WICKLIFFE J K, DERTINGER S D, TOROUS D K, et al. Dietinduced obesity increases the frequency of Pig-a mutant erythrocytes in male C57BL/6J mice[J]. Environ Mol Mutagen, 2016, 57(9):668-677.
[41] ARATEN D J, BESSLER M, MCKENZIE S, et al. Dynamics of hematopoiesis in paroxysmal nocturnal hemoglobinuria (PNH):no evidence for intrinsic growth advantage of PNH clones[J]. Leukemia, 2002, 16(11):2243-2248.
[42] BEMIS J C, HEFLICH R H. In vitro mammalian cell mutation assays based on the Pig-a gene:A report of the 7th International Workshop on Genotoxicity Testing (IWGT) Workgroup[J]. Mutat Res-Gen Tox En, 2019, 847:403028.
[43] WANG T W, TU Y T, WANG K, et al. Associations of blood lead levels with multiple genotoxic biomarkers among workers in China:a population-based study[J]. Environ Pollut, 2020, 273:116181.
[44] BONETTO R M, CASTEL P, ROBERT S P, et al. Evaluation of PIG-Amutated granulocytes and ex-vivo binucleated micronucleated lymphocytes frequencies after breast cancer radiotherapy in humans[J]. Environ Mol Mutagen, 2021, 62(1):18-28. |
